Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EHSG-KF versus split-thickness skin graft for deep burns
NL-OMON55581Phase 2Recruiting
- Sponsor
- CUTISS
- Start
- Jan 2020
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of denovoSkin in burn injury and deep partial-thickness burn (2 arms), sponsored by CUTISS. Started Jan 2020; status: recruiting.
02
Drugs
denovoSkin
03
Conditions
burn injurydeep partial-thickness burn
Beyond the preview
Go deeper on NL-OMON55581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55581.